Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ISK Biosciences is a specialized life sciences company focused on the research, development, and registration of innovative agrochemical products. As a subsidiary of the Japanese chemical conglomerate Ishihara Sangyo Kaisha, Ltd. (ISK), the company serves as the primary hub for North American operations, particularly in the crop protection sector. ISK Biosciences manages a diverse portfolio of proprietary active ingredients, including fungicides, herbicides, and insecticides designed to enhance agricultural productivity. While the parent company also maintains a presence in the pharmaceutical industry with products like nartograstim, ISK Biosciences specifically concentrates on advancing chemical and biological solutions for the global agricultural market. The company is recognized for its expertise in navigating complex regulatory environments to bring new crop protection technologies to commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ISK Biosciences.